Gilead Sciences
GILD
#113
Rank
$167.86 B
Marketcap
$135.29
Share price
3.16%
Change (1 day)
47.47%
Change (1 year)

Market capitalization of Gilead Sciences (GILD)

Market cap: $167.86 Billion USD

As of January 2026 Gilead Sciences has a market cap of $167.86 Billion USD. This makes Gilead Sciences the world's 113th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Gilead Sciences from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026$167.86 B8.49%
2025$154.72 B31.92%
2024$117.28 B16.19%
2023$100.94 B-6.25%
2022$107.67 B18.26%
2021$91.05 B24.68%
2020$73.03 B-11.22%
2019$82.26 B2.59%
2018$80.18 B-14.31%
2017$93.58 B-0.81%
2016$94.34 B-34.43%
2015$143.89 B1.84%
2014$141.29 B22.62%
2013$115.23 B106.55%
2012$55.79 B81.47%
2011$30.74 B5.78%
2010$29.06 B-25.35%
2009$38.93 B-16.39%
2008$46.56 B8.95%
2007$42.73 B42.74%
2006$29.94 B23.89%
2005$24.16 B53.89%
2004$15.70 B26.36%
2003$12.42 B84.99%
2002$6.71 B5.91%
2001$6.34 B62.22%
2000$3.91 B63.84%
1999$2.38 B89.26%
1998$1.26 B9.73%
1997$1.14 B59.86%
1996$0.71 B

End of Day market cap according to different sources

On Jan 22nd, 2026 the market cap of Gilead Sciences was reported to be:

$162.70 Billion USD
by Nasdaq info icon info icon
$162.71 Billion USD
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
$185.23 B 10.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
$118.88 B-29.18%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
$384.75 B 129.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
$22.98 B-86.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$25.04 B-85.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$145.52 B-13.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$526.26 B 213.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$960.45 B 472.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$268.88 B 60.18%๐Ÿ‡บ๐Ÿ‡ธ USA